ProArgi-9 Plus Clinical Trial

High Desert Heart Institute is an affiliate of Cedars-Sinai Hospital and provides stellar primary care and heart disease services to its high-risk patient base.

Clinic Trial Goals

To evaluate the cardiovascular and associated benefits of using ProArgi-9 Plus dosed at high levels. 35 Test Participants under direction of Dr. Joe Prendergast and High Desert Heart Institute Physicians start to take 20gramms in the morning, for 30, 60 & 90 day periods.

Disease Category Subsets

  • PVD (Peripheral Vascular Disease)
  • Angina
  • Malignant Hypertension
  • Diabetes Mellitus
  • Pulmonary Arterial Hypertension

100% of Patients will get below labs (baseline and 90 day)

  • CMP (Complete Metabolic Panel) Microalbumin
  • CBC (Complete Blood Count) Plac Test (diaDexus)
  • HgbA1c Hemoglobin 90 day test LFT (Liver Function Test)
  • Full Lipid Panel BNP (B-Naturetic Peptide Levels)
  • Vitamin D3 levels CRP (C-Reactive Protein)

Further Diagnostic Tests

  • Echocardiogram
  • Cardio Dynamic Analysis (BioZ)
  • 6 Minute Walk Test
  • Coronary Calcium Score: (Computerized tomography)
  • Coronary CT Angio IV Contrast
  • Ankle - Brachial Index
  • Cardio Pulsewave Analysis (B-Pro)
  • Doppler Echo
  • Blood Oxygen Saturation Levels (APRIA Health)

We are now at day 64 of the 90 day clinical trial for the first group of three groups that entered the trial in the week of February 2nd, 2009 and are now 2/3rd of the way through the initial trial while groups two and three are once week and two weeks behind respectively.

  • Trend #1: Virtually all participants with elevated blood pressures have seen such significant reductions in B.P. that the attending physicians have begun down titrating (reducing strengths) their B.P. medications.
  • Trend #2: Virtually all participants are seeing increased vessel functions and blood flows.
  • Trend #3: Many participants are making directs comments regarding their energy levels and tolerance of exercise.
  • Trend #4: Virtually all participants that were suffering from diminished pulmonary (lung) function or blood oxygen saturation levels are seeing marked improvements resulting in significantly increased strength and endurance.

Female Patient 1

Morbidly obese, diabetic with significant vascular neuropathy and pain:

This patient’s pain greatly reduced with the first few weeks after beginning on ProArgi-9 Plus. Unknown to the trial doctor, her attending Endocrinologist mid-study changed her diabetic medication resulting in an increasing blood sugar level.

The patient believing the increase was due to the ProArgi-9, without guidance from her physician, took herself off ProArgi-9 Plus which caused a return of the vascular neuropathy pain within a few days.

Upon discussing the event with the director of the study, the endocrinologist consulted with the patient and the diabetic medication was changed back to the original prescription. After the blood sugars normalized, the patient once again began taking ProArgi-9 Plus and which a few days the pain from the vascular neuropathy abated and to this date, non-existent.

Male Patient 1

Significantly developed coronary heart disease with daily angina (heart pain):

This participant was using 6-12 nitroglycerin pills per day to address the blood flow constriction resulting in angina and is as of this date currently using 1-3 nitroglycerine pills per day.

Male Patient 2

Significantly developed coronary heart disease with daily angina (heart pain):

This participant was using 4-9 nitroglycerine pills per day to address the blood flow constriction resulting in angina and as of this date has gone 3 weeks without the need of any nitroglycerine medications.

ATTENTION

Since the above information was released the Clinical Trial is now complete. The results of the Trial have been outstanding and it is expected that publication will be available by the end of August 2009.

The final Word from Denise Brown - Synergy Products

After listening to the recording of the findings last week I was over whelmed by uncontrollable excitement. All my beliefs in ProArgi-9 Plus seemed to be vindicated by the top medical minds and this research was not instigated by the company.

Wow - This clinical trial will absolutely rock the industry to its boots.